Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:54:41.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0, replacing the previous version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-16T01:58:06.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T21:39:20.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:05:35.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:29:53.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T05:50:20.000Z thumbnail image

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.